Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: no known allergies / adverse drug reactions attending: chief complaint: peri-hepatic fluid collection major surgical or invasive procedure: - ct-guided drainage of a gallbladder fossa collection with percutaneous drain placement. history of present illness: this is a 70-year old male with history of unresectable pancreatic cancer s/p ex-lap, open cholecystectomy and retroperitoneal lymph node biopsies on , discharged on with a post-op course complicated by gram negative bacteremia and delirium. he was transferred from hospital with 5 days of abdominal pain, nausea and vomiting. he has been having less frequent bowel movements (last was 3 days ago) and reported not passing flatus for the past 2 days. he denied any fevers or chills. kub was without evidence bowel obstruction. past medical history: pmh: copd, on home oxygen 2l continuously; anxiety; depression; osa; hx of arf; dmii, htn, cad s/p ptca yrs bu, ?seizures vs. syncope psh: open appendectomy, tonsillectomy, bilateral carotid stents social history: patient retired (used to work for oxygen device company) and lives with his mother in . has 5 children. previously smoked 3-4 packs/day x 45 years gradually decreasing for past 8 years, now 0.75 pack per day. patient states he quit alcohol 30 years ago. prior crack/cocaine x 2 yrs. quit a few yrs ago. family history: mother cabg , alive 95. father died at of pancreatic cancer at age 72. physical exam: physical exam (on admission): vitals: t 98.9 hr 86 bp 163/91 rr 16 so2 96% gen: a&o, nad heent: no scleral icterus, mucus membranes moist cv: rrr, no m/g/r pulm: clear to auscultation b/l, no w/r/r abd: soft, mildly distended, mildly tender to palpation on ruq and periumbilical area, no rebound or guarding dre: normal tone, no gross or occult blood. guaiac neg. ext: no le edema, le warm and well perfused pertinent results: 03:15pm blood wbc-26.0*# rbc-4.05* hgb-12.3* hct-39.7*# mcv-98 mch-30.4 mchc-31.0 rdw-17.0* plt ct-637*# 03:15pm blood neuts-88.4* lymphs-8.9* monos-2.2 eos-0.3 baso-0.2 03:15pm blood pt-14.7* ptt-21.7* inr(pt)-1.3* 03:15pm blood glucose-116* urean-12 creat-0.8 na-144 k-3.6 cl-101 hco3-31 angap-16 03:15pm blood alt-65* ast-103* alkphos-958* totbili-1.1 04:25am blood calcium-8.3* phos-2.9 mg-1.2* 06:30am blood vanco-21.7* 03:32pm blood lactate-1.6 ct abd & pelvis with contrast - in the right lobe of the liver, there is a rim enhancing collection measuring 4.0 x 5.6 cm that contains foci of air, concerning for abscess. increased ascites compared to the prior exam. increased intrahepatic biliary duct and pancreatic duct dilation, likely secondary to known pancreatic mass. ct guided needle plactment - technically successful ct-guided aspiration drainage of a gallbladder fossa collection. 8 french catheter placed. 30 cc of purulent material were aspirated to bag and gravity. 1 cc was sent for microbiology specimen. no immediate complications. brief hospital course: neuro/pain: the patient was maintained on iv pain medication on admission and transitioned to po narcotic medication with adequate pain control on hod#x once oral intake was tolerated. the patient remained neurologically intact and without change from baseline during their stay. his home dosing of benzodiazepines was continued without evidence of delirium or mental status change. the patient remained alert and oriented to person, location and place. cardiovascular: the patient remained hemodynamically stable. the patient was maintained on iv anti-hypertensive medication, with transition to their oral home anti-hypertensives on hod#. their vitals signs were closely monitored. the patient's home anti-hypertensive medications were resumed on hod#3. unfortunately, the patient developed ventricular tachycardia prior to ercp in the setting of hypokalemia and hypomagnesemia. he required amiodarone boluses and synchronized cardioversion to revert to sinus rhythm. he was transferred to the icu for monitoring. patient treated with esmolol drip overnight and remained in sinus rhythm throughout. esmolol drip stopped and patient placed back on home metoprolol. he tolerated this well and cardiology agreed with this management. he was transfered out of the icu and did well on oral metoprolol up to discharge without any hemodynamic instability. respiratory: the patient had no episodes of desaturation or pulmonary concerns. the patient denied cough or respiratory symptoms. pulse oximetry was monitored closely and the patient maintained adequate oxygenation. gastrointestinal: the patient was npo on admission and on hod#2 experienced significant abdominal distention and episodic emesis requiring nasogastric tube placement. the ngt was discontinued on hod#3 and was replaced on hod#6 when complained of increasing abdominal discomfort and epigastric bloating. the second ngt placement resulted in 2.5l of bilious return. he was eventually showing improvement, the ngt was removed and clear liquids were tolerated. he did receive 2-days of supplemental tpn, but this was discontinued and the patient was again allowed to maintain a regular diet, as tolerated. the patient underwent a ct of the abdomen and pelvis on admission that showed a right lobe of the liver rim enhancing collection measuring 4.0 x 5.6 cm that contained foci of air, concerning for abscess. there was increased ascites compared to the prior exam and increased intrahepatic biliary duct and pancreatic duct dilation, likely secondary to known pancreatic mass. he underwent ct-guided aspiration and drainage of a gallbladder fossa collection on hod#2 with placement of an 8-french catheter, and 30 cc of purulent material were aspirated to bag and gravity. 1-cc was sent for microbiology specimen. the culture returned mixed bacterial flora and he was started on vancomycin and zosyn iv on admission. he was continued on these antibiotics until po intake was established, at which time the patient was transitioned to oral augmentin. iv antibiotics were resumed when his icu transfer was instated, and a 10-day course was completed. the drainage catheter was removed prior to discharge. patient underwent ercp with placement of mental biliary stent. the duodenal was not obstructed as previously thought and no stents were placed. oncology and palliative consults were obtained. he was discharged with heme/oncology and palliative care follow-up regarding possible chemotherapy and hospice services. genitourinary: the patient's urine output was closely monitored in the immediate post-operative period. a foley catheter was placed on admission to monitor urine output and was removed on hod#2, at which time the patient was able to successfully void without issue. the patient's intake and output was closely monitored for urine output > 30 ml per hour output. the patient's creatinine was stable. heme: the patient's hematocrit was stable and trended closely. he did have a single episode of bloody bowel movement which resolved without issue; and serial hematocrits were stable. the patient remained hemodynamically stable and did not require transfusion. the patient's coagulation profile remained normal. the patient had no evidence of bleeding. id: the patient was admitted with a wbc of 26.0 which trended down following drainage and iv antibiotic treatment. the patient underwent a ct of the abdomen and pelvis on admission that showed a right lobe of the liver rim enhancing collection measuring 4.0 x 5.6 cm that contained foci of air, concerning for abscess. there was increased ascites compared to the prior exam and increased intrahepatic biliary duct and pancreatic duct dilation, likely secondary to known pancreatic mass. he underwent ct-guided aspiration and drainage of a gallbladder fossa collection on hod#2 with placement of an 8-french catheter, and 30 cc of purulent material were aspirated to bag and gravity. 1-cc was sent for microbiology specimen. the culture returned mixed bacterial flora and he was started on vancomycin and zosyn iv on admission. he was continued on these antibiotics until po intake was established, at which time the patient was transitioned to oral augmentin. however, he was restarted on iv antibiotics when transfered to the icu and these were completed during his hospitalization. the drainage catheter was kept in place on discharge. blood and urine cultures were unrevealing. he remained afebrile on admission, despite the above collection. endocrine: the patient's blood glucose was closely monitored with q6 hour glucose checks. blood glucose levels greater than 120 mg/dl were addressed with an insulin sliding scale. prophylaxis: the patient was maintained on heparin 5000 units sq tid for dvt/pe prophylaxis and encouraged to ambulate immediately once cleared by physical therapy. the patient also had sequential compression boot devices in place during immobilization to promote circulation. gi prophylaxis was sustained with protonix/famotidine when necessary. the patient was encouraged to utilize incentive spirometry, ambulate early and was discharged in stable condition with follow-up with hospice and heme/oncology appointments. he will have vna nursing services and pt support as a bridge to hospice care. medications on admission: albuterol 5 mg/ml neb prn, alprazolam 1 mg'''', plavix 75 mg', effexor 75 mg' qod, finasteride 5 mg', fluticasone-salmeterol 250/50 mcg', glipizide 2.5 mg'', ipatroprium-albuterol 18/103 mcg'', lisinopril 10 mg', metoprolol 100 mg', percocet 5/325 mg qid prn, promethazine 6.25 mg/5 ml' 0.5 (one half) teaspoon daily, aspirin 325 mg', docusate 100 mg', flaxseed oil, magnesium oxide 400 mg'', omega-3 fas 1000 mg'', lidocaine 5 % topical cream as needed discharge medications: 1. fluticasone-salmeterol 250-50 mcg/dose disk with device sig: one (1) disk with device inhalation daily (daily). 2. lisinopril 10 mg tablet sig: one (1) tablet po daily (daily). 3. aspirin 325 mg tablet sig: one (1) tablet po daily (daily). 4. calcium carbonate 200 mg calcium (500 mg) tablet, chewable sig: one (1) tablet, chewable po qid (4 times a day) as needed for heartburn. 5. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 6. tamsulosin 0.4 mg capsule, ext release 24 hr sig: one (1) capsule, ext release 24 hr po hs (at bedtime). 7. glipizide 5 mg tablet sig: 0.5 tablet po bid (2 times a day). 8. venlafaxine 37.5 mg tablet sig: one (1) tablet po qod (). 9. morphine 10 mg/5 ml solution sig: ml po q4h (every 4 hours). disp:*300 ml* refills:*0* 10. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 11. metoprolol succinate 100 mg tablet extended release 24 hr sig: one (1) tablet extended release 24 hr po once a day. 12. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*2* 13. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*60 tablet(s)* refills:*2* 14. lorazepam 0.5 mg tablet sig: one (1) tablet po bid (2 times a day). 15. lorazepam 0.5 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for anxiety, agitation, signs of withdrawal. discharge disposition: home with service facility: vna discharge diagnosis: peri-hepatic abscess/fluid collection discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - requires assistance or aid (walker or cane). discharge instructions: you were admitted to dr. surgical service for evaluation and management of your peri-hepatic fluid collection. you are now being discharged home. please follow these instructions to aid in your recovery: please call your doctor or go to the emergency department if: * you experience new chest pain, pressure, squeezing or tightness. * you develop new or worsening cough, shortness of breath, or wheezing. * you are vomiting and cannot keep down fluids, or your medications. * if you are getting dehydrated due to continued vomiting, diarrhea, or other reasons. signs of dehydration include: dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. * you see blood or dark/black material when you vomit, or have a bowel movement. * you experience burning when you urinate, have blood in your urine, or experience an unusual discharge. * your pain is not improving within 12 hours or is not under control within 24 hours. * your pain worsens or changes location. * you have shaking chills, or fever greater than 101.5 degrees fahrenheit or 38 degrees celsius. * you develop any other concerning symptoms. general discharge instructions: * please resume all regular home medications, unless specifically advised not to take a particular medication. * please take any new medications as prescribed. * please take the prescribed analgesic medications as needed. you may not drive or operate heavy machinery while taking narcotic analgesic medications. you may also take acetaminophen (tylenol) as directed, but do not exceed 4000 mg in one day. * please get plenty of rest, continue to walk several times per day, and drink adequate amounts of fluids. * avoid strenuous physical activity and refrain from heavy lifting greater than 10 lbs., until you follow-up with your surgeon, who will instruct you further regarding activity restrictions. * please also follow-up with your primary care physician. followup instructions: you will be contact by hospice of & greater regarding hospice options. there number is - please contact them this week regarding follow-up with them. you will be contact by the outpatient hematology/oncology service regarding a follow-up appointment; if you don't hear from them in days, please call their office at (. provider: function lab phone: date/time: 11:40 provider: ,interpret w/lab no check-in intepretation billing date/time: 12:00 provider: , m.d. phone: date/time: 12:00 procedure: venous catheterization, not elsewhere classified venous catheterization, not elsewhere classified parenteral infusion of concentrated nutritional substances endoscopic insertion of stent (tube) into bile duct percutaneous aspiration of liver diagnoses: obstructive sleep apnea (adult)(pediatric) coronary atherosclerosis of native coronary artery unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) percutaneous transluminal coronary angioplasty status paroxysmal ventricular tachycardia dysthymic disorder abscess of liver obstruction of bile duct delirium due to conditions classified elsewhere malignant neoplasm of other specified sites of pancreas 

Answer: The patient is high likely exposed to